The molecular subtyping of breast cancer and its clinical treatment significance / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 2309-2312, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-807835
ABSTRACT
The breast cancer is a usual and serious malignant tumor which threatens the women′s health.Molecular subtyping bases on the molecular level, and provides a new classification method for the breast cancer pathology classification, and plays an important guidance significance for the clinical treatment.At present, the breast cancer molecular subtyping is mainly divided into the following subtypes the Luminal A type and Luminal B type, HER-2 overexpression and the triple negative breast cancer.Different molecular subtyping has different characteristics in treatment reaction, prognosis and the clinical application situation.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
/
Estudio pronóstico
Idioma:
Chino
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS